Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro

Background. Resistance to radiation therapy poses a major clinical problem for patients suffering from head and neck squamous cell carcinoma (HNSCC). Transforming growth factor ß (TGF-ß) has emerged as a potential target. This study aimed to investigate the radiosensitizing effect of galunisertib, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jank, Bernhard J., Lenz, Teresa, Haas, Markus, Kadletz-Wanke, Lorenz, Campion, Nicholas J., Schnoell, Julia, Heiduschka, Gregor, Macfelda, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098568/
https://www.ncbi.nlm.nih.gov/pubmed/34985593
http://dx.doi.org/10.1007/s10637-021-01207-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098568/
https://www.ncbi.nlm.nih.gov/pubmed/34985593
http://dx.doi.org/10.1007/s10637-021-01207-1

Ejemplares similares